Search

Author/Creator Lee, Jae Lyun

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016)

Authors:
Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze Heng; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David J.; Fradet, Yves; Lee, Jae Lyun; Fo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial. Issue 10189 (15th June 2019)

Authors:
Rini, Brian I; Powles, Thomas; Atkins, Michael B; Escudier, Bernard; McDermott, David F; Suarez, Cristina; Bracarda, Sergio; Stadler, Walter M; Donskov, Frede; Lee, Jae Lyun; Hawkins, Robert; Ravaud, Alain; Alekseev, Boris; Staehler, Michael; Uemura, Motohide; De Giorgi, Ugo; Mellado, Begoña; Por...
Journal:
Lancet
Issue:
Volume 393:Issue 10189(2019)
Page Start:
2404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. (18th January 2021)

Authors:
Gan, Chun Loo; Dudani, Shaan; Wells, J. Connor; Donskov, Frede; Pal, Sumanta K.; Dizman, Nazli; Rathi, Nityam; Beuselinck, Benoit; Yan, Flora; Lalani, Aly‐Khan A.; Hansen, Aaron; Szabados, Bernadett; de Velasco, Guillermo; Tran, Ben; Lee, Jae Lyun; Vaishampayan, Ulka N.; Bjarnason, Georg A.; Suba...
Journal:
Cancer medicine
Issue:
Volume 10:Number 4(2021)
Page Start:
1212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. Issue 7 (July 2016)

Authors:
Choueiri, Toni K; Escudier, Bernard; Powles, Thomas; Tannir, Nizar M; Mainwaring, Paul N; Rini, Brian I; Hammers, Hans J; Donskov, Frede; Roth, Bruce J; Peltola, Katriina; Lee, Jae Lyun; Heng, Daniel Y C; Schmidinger, Manuela; Agarwal, Neeraj; Sternberg, Cora N; McDermott, David F; Aftab, Dana T;...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 7(2016:Jul.)
Page Start:
917
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index. Issue 21 (May 2016)

Authors:
Choi, Yun Mi; Kwon, Hyemi; Jeon, Min Ji; Sung, Tae-Yon; Hong, Suck Joon; Kim, Tae Yong; Kim, Won Bae; Shong, Young Kee; Lee, Jae Lyun; Song, Dong Eun; Kim, Won Gu
Editors:
Gurzu., Simona
Journal:
Medicine
Issue:
Volume 95:Issue 21(2016)
Page Start:
e3736
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index. Issue 21 (May 2016)

Authors:
Choi, Yun Mi; Kwon, Hyemi; Jeon, Min Ji; Sung, Tae-Yon; Hong, Suck Joon; Kim, Tae Yong; Kim, Won Bae; Shong, Young Kee; Lee, Jae Lyun; Song, Dong Eun; Kim, Won Gu
Other Names:
Gurzu. Simona section editor.
Journal:
Medicine
Issue:
Volume 95:Issue 21(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Issue 2 (February 2022)

Authors:
Siefker-Radtke, Arlene O; Necchi, Andrea; Park, Se Hoon; García-Donas, Jesús; Huddart, Robert A; Burgess, Earle F; Fleming, Mark T; Rezazadeh Kalebasty, Arash; Mellado, Begoña; Varlamov, Sergei; Joshi, Monika; Duran, Ignacio; Tagawa, Scott T; Zakharia, Yousef; Akapame, Sydney; Santiago-Walker, Ad...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 2(2022)
Page Start:
248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗